Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Novavax may be able to provide equitable access to another vaccine alternative

Vibhav Prabhakar, Tejas Sekhar, and Divya Srinivasan
Meds
July 7, 2022
Share
Tweet
Share

On June 7th, 2022, the Novavax COVID-19 vaccine was approved for use in adults by the Vaccine Advisory Committee of the United States Food and Drug Administration. The vaccine has already been authorized in many other nations, including Indonesia, the United Kingdom, Canada, Australia, and more, making the U.S. one of the last major nations to approve the vaccine.

The technology behind Novavax differs from the already prominent Pfizer and Moderna vaccines in that it uses a more traditional and time-intensive approach that involves identifying and manipulating purified proteins to induce an effective immune system response. This process has been used for decades to combat diseases like hepatitis, shingles, and influenza, among others, and this methodology may make Novavax the better vaccine relative to the current mRNA and viral vector-based vaccines on the market for several reasons. Though uncommon, vaccines like Pfizer and Moderna have resulted in dangerous side effects such as heart inflammation and blood clots. Protein-based vaccines like Novavax, on the other hand, are cheaper, have greater efficacy, and are less likely to result in short-term side effects or long-term complications. Current estimates project the vaccine to cost about $16 per injection in comparison to the $23.15 and $25.50 for Pfizer and Moderna, respectively. Novavax presently plans to send “a few million doses” in their first shipment to the U.S.

Although the FDA’s Vaccine Advisory Committee has extended approval, Novavax has not been given full clearance to be distributed in the United States. According to current data from the Phase 3 clinical trial that has been conducted, the vaccine is 90 percent effective against COVID-19 symptomatic infection and 100 percent against moderate and severe disease. Approximately 30,000 participants aged 18 and older were a part of this study as reported in the New England Journal of Medicine in December 2021. However, it is important to keep in mind that this data was gathered prior to the spread of the Omicron variant and may not reflect the vaccine’s true efficacy against more recent strains. Given its traditional approach to developing vaccines, Novavax hopes to reach citizens who may not have been comfortable with previous mRNA vaccines due to the side effects or vaccine hesitancy. Additionally, it boasts the ability to be stored at refrigerator temperatures for months, allowing for a longer shelf life than mRNA-based vaccines.

But how much of an effect will Novavax really have? 89 percent of American adults have already received at least one dose of a vaccine, leaving possibly little room for Novavax to have a significant impact. However, the global health community remains optimistic about the future to come. Dr. Peter Marks, the Director of the Center for Biologics Evaluation and Research (CBER), has suggested that a protein-based alternative may have a greater reuptake than previous vaccines as individuals might be more comfortable with this type of vaccine. All things considered, Novavax may be able to provide equitable access to another vaccine alternative that could protect our communities and further curb the spread of COVID-19.

Vibhav Prabhakar is a high school student. Tejas Sekhar is a graduate student. Divya Srinivasan is an undergraduate student.

Image credit: Shutterstock.com

Prev

6 changes that could lower the risk of developing prostate cancer

July 7, 2022 Kevin 0
…
Next

If it's not clinically pertinent, then stay out of my uterus

July 7, 2022 Kevin 1
…

Tagged as: COVID

Post navigation

< Previous Post
6 changes that could lower the risk of developing prostate cancer
Next Post >
If it's not clinically pertinent, then stay out of my uterus

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Related Posts

  • HIV/AIDS vaccine underscores need for better health access

    Alyson O’Daniel, PhD
  • The basics of the MMR vaccine from a pediatrician

    Roy Benaroch, MD
  • No, the HPV vaccine isn’t optional

    Chad Hayes, MD
  • A view from Canada: Defending vaccine passports

    Bryan Thomas and Colleen M. Flood
  • Major medical groups back mandatory COVID vaccine for health care workers

    Molly Walker
  • People over profit: Pfizer and Moderna must share vaccine technology

    Amber Gipson-Fine, MPH

More in Meds

  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • Why male fertility needs to be part of every health conversation

      Hoag Memorial Hospital Presbyterian | Conditions
    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Inside human trafficking: a guide to recognizing and preventing it [PODCAST]

      The Podcast by KevinMD | Podcast
    • Graduating from medical school without family: a story of strength and survival

      Anonymous | Education
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
  • Recent Posts

    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Adriana Smith’s story: a medical tragedy under heartbeat laws

      Nicole M. King, MD | Physician
    • What if medicine had an exit interview?

      Lynn McComas, DNP, ANP-C | Conditions
    • Why U.S. health care pricing is so confusing—and how to fix it

      Ashish Mandavia, MD | Physician
    • From survival to sovereignty: What 35 years in the ER taught me about identity, mortality, and redemption

      Kenneth Ro, MD | Physician
    • When doctors forget how to examine: the danger of lost clinical skills

      Mike Stillman, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • Why male fertility needs to be part of every health conversation

      Hoag Memorial Hospital Presbyterian | Conditions
    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Inside human trafficking: a guide to recognizing and preventing it [PODCAST]

      The Podcast by KevinMD | Podcast
    • Graduating from medical school without family: a story of strength and survival

      Anonymous | Education
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
  • Recent Posts

    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Adriana Smith’s story: a medical tragedy under heartbeat laws

      Nicole M. King, MD | Physician
    • What if medicine had an exit interview?

      Lynn McComas, DNP, ANP-C | Conditions
    • Why U.S. health care pricing is so confusing—and how to fix it

      Ashish Mandavia, MD | Physician
    • From survival to sovereignty: What 35 years in the ER taught me about identity, mortality, and redemption

      Kenneth Ro, MD | Physician
    • When doctors forget how to examine: the danger of lost clinical skills

      Mike Stillman, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...